affiliation.png
Affiliations
Our affiliations are indicative of our dedication to the health science community.
We are actively engaged in professional organizations dedicated to promoting innovation, modernizing
and harmonizing the regulatory landscape, as well as disseminating best practices for health products development.



A3P Suisse. The Association for clean and sterile products, is a major player in the pharma and biotech industry, serving more than 1,000 members, suppliers and manufacturers. A3P runs a professional network of over 21,000 contacts worldwide including regulatory monitoring, information, training, exchange. A3P 2 international conferences and 10 events for professionals in the pharma and biotech annually.



The Association Des Cadres de I’Industrie Pharmaceutique (ACIP) was founded in 1956 and is for managers of all specialties and all sources in the pharmaceutical industry. ACIP acts as a place of information exchange and professional expression with about 1,000 members and supporters, cadres of the pharmaceutical industry from all hierarchical levels, from CEO to junior managers.


Alliance for Regenerative Medicine (ARM) promotes the interests of the regenerative medicine by representing, supporting and engaging all stakeholders in the field, including companies, academic research institutions, patient advocacy groups, foundations, health insurers, financial institutions and other organizations.


Association Française des Affaires Réglementaires (AFAR).The French Association of Regulatory Affairs brings together Regulatory Affairs professionals working in the healthcare industry for over 20 years. AFAR allows to share thoughts and experiences between professionals. The Professions related to Regulatory Affairs include different activities according to business structures and sector (medicine, medical devices, cosmetics, etc).


Association des Médecins des Industries des Produits de Santé (AMIPS).The AMIPS is an organization of Industry players committed to responsible health, bringing together all the medical professions in IPS: doctors, pharmacists, scientists, lawyers, biostatisticians, economists, recruiters. AMIPS interests, focused on the areas of medicine, are also extended to the areas of the drug, medical device, diagnostics, health and nutrition dermocosmetology.


The Association of Biotechnolgy Led Entreprises (ABLE) is a forum that represents India Unique Biotech Environment and is envisaged as the collective face of the Indian Biotech Industry. ABLE help generate a symbiotic interface between the industry, the government, academic and research bodies, and domestic and international investors.


The Association of Medical Diag. Manufacturers (AMDM, USA) which is a nonprofit trade association that serves as an educational resource for regulatory submissions and other compliance information related to the in vitro diagnostic industry. AMDM organises educational conferences in which the FDA and other regulatory bodies share information and exchange ideas with industry.


The Atlanpole Biotherapies (ATLANPOLE) competitive cluster combines the expertise of laboratories, companies and technical departments for a public-private offer of services, comprehensive, relevant and competitive, in the value chain of bio-medicine from target discovery to clinical evaluation.


The British Holistic Medical Association (BHMA) aims to promote holistic practice and to revitalise mainstream medicine. The BHMA provides a forum to share information and discuss issues; it is committed to providing opportunities for people to learn more about holistic practice; and it provides a collective voice for all those seeking to change the way in which healthcare is delivered.


The Centres Régionaux d'Innovation et de Transfert Technologique (CRITT) seeks to adapt to technological and economic constraints of its partners and integrating scientific advanced topic. CRITT caters to the needs of small and medium enterprises and aims to support innovation process and to provide advice to project developers including entrepreneurs.


The Chambre France-Suisse pour le Commerce et l’Industrie (CFSCI) has 500 member companies and aims to bring together the French business community in Switzerland and support French and Swiss companies seeking to develop and expand into one or the other markets.


The Chambre vaudoise du commerce et l’industrie (CVCI) which promots the development of trade and industry. It provides member companies all the advantages of an association in a privileged setting, promotes openness by stimulating competitiveness and a harmonious development of the private sector, and appropriate interventions for policy makers in Switzerland and abroad.


California Life Sciences Association (CLSA) was founded in 2015 from the merger of the Bay Area Bioscience Association (BayBio) and the CHI Institute. They serve biotechnology, pharmaceutical, medical device and diagnostics companies, research universities and institutes, investors and service providers; working closely with industry, government, academia and others to shape public policy, improve access to innovative technologies and grow California’s life sciences economy.


Développement économique du Canton de Vaud (DEV). The Economic Development - Canton de Vaud which is a private association, financed by the Canton of Vaud and its members and especially a home and support organization for foreign companies in the implementation of their activities They help in promoting the economy, the development of new businesses and creating new jobs.


The Drug Information Association Europe (DIA) which is a neutral, nonprofit, global, professional association of nearly 18,000 members who work in every facet of the discovery, development, and life cycle management of pharmaceuticals, medical devices, and related products. DIA is committed to the broad dissemination of information, with continuously improved professional practice as the goal.


European Association for bio-industries (EuropaBio). EuropaBio’s mission is to promote an innovative and dynamic biotechnology-based industry in Europe. EuropaBio, (the European Association for Bioindustries), has 72 corporate and 6 associate members operating worldwide, 4 Bioregions and 25 national biotechnology associations representing some 1800 small and medium sized enterprises.


The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) which promotes companies and associations active in research, development, production and distribution of pharmaceutical products and enhance their scientific, technical, economic and legal objectives. EUCOPE represents member companies operating in Europe with respect to the EU institutions and agencies.


The European Nutraceutical Association (ENA) is devoted to providing a scientific platform for nutraceuticals. The ENA sees its main task in providing a platform for nutrition specialists who want to explore nutraceuticals in depth.


The European Personalised Medicine Association (EPEMED) is a European, non profit organisation bringing together global forces in personalised medicine. The association was founded to address issues in personalised medicine that confront the industry, regulators, payers & insurers and governments. The organisation aims to improve the application and development of diagnostic tools for patients.


France Biotech is the French association of life science businesses and their partners. France Biotech is a driving force for change; it lobbies public authorities, economic organizations, academic research, the media and, particularly, the investor community in order to promote the emergence of biotechnology as a top-priority, hi-tech industry.


Groupement Romand de l'Industrie Pharmaceutique (GRIP). GRIP represents and promotes the professional and business interests of members to the authorities (Swissmedic, BSV, cantonal pharmacists, or other as appropriate). Grip collaborates with other professional groups in the field of health, provides a platform for exchange pharmaceutical industries and promotes cooperation between pharmaceutical partners.


L'association française des Sociétés de Services et d'Innovation (AFSSI). The French Association Services Companies and Innovation for Life Sciences aims to bring together the French service companies and technological innovation in the strategic area of Life Sciences. The AFSSI represents economical "services-technologies" rooted in a pragmatic entrepreneurial process models for helping innovative companies.


The Massachusetts Biotechnology Council (MassBio), an association of more than 650 biotechnology companies, universities, academic institutions and others dedicated to advancing cutting edge research; and the leading advocate for the Bay State’s world premier life science cluster.


OBN is a not-for-profit membership organization, supporting and bringing together the UK’s innovative life sciences companies, corporate partners and investors. Their 400-plus member companies are located across the golden triangle and beyond to Nottingham, Manchester and Scotland, benefiting from their networking, partnering, purchasing, advising and advocacy activities.


The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. The PDA is a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its members worldwide.


Regulatory Affairs Professionals Society (RAPS) is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization.


Swiss Association of Pharmaceutical Professionals (SwAPP) is a professional association for qualified specialists working in one of the many fields of pharmaceutical medicine and drug development. SwAPP supports members in the performance of their professional duties in clinical research and development, networking and to promote the acquisition and dissemination of knowledge concerning best practices in clinical research and develoment.


Swiss BioAlps. The mission of BioAlps is to be recognized worldwide as a leading brand and to sustain growth of our Biotech and Medtech industry in Switzerland.


Swiss Biotech Association (SBA). The SBA is a joint project by the federal agencies CTI/KTI (Commission for Technology and Innovation), seco and BBT. The site is a non-for profit project and intends to create awareness for the sector. The SBA aims to bring together leading life science clusters of Switzerland and support them with regulatory, tech transfer, research, finances etc.


Swissnex Boston is a public-private venture which bridges the knowledge, energy and expertise in science, higher education and innovation, between Switzerland and the greater Boston area, by offering services to Swiss universities, start-ups and corporations. VCLS is a preferred partner for Swissnex Boston.


The Organisation for Professionals in Regulatory Affairs (TOPRA) which is the professional membership organisation for individuals working in healthcare regulatory affairs. TOPRA works towards representing and promoting the global healthcare regulatory profession; and providing members with top-quality, relevant support with a European focus.


The U.S. Pharmacopeial Convention (USP) which is a scientific nonprofit organization that sets standards for the identity, strength, quality, and purity of medicines, food ingredients, and dietary supplements manufactured, distributed and consumed worldwide. USP’s drug standards are enforced by the Food and Drug Administration, and are used in more than 140 countries.